Literature DB >> 30868522

Production of Recombinant Trypanosoma cruzi Antigens in Leishmania tarentolae.

María José Ferrer1, Diana Patricia Wehrendt1, Mariana Bonilla2, Marcelo Alberto Comini2, María Teresa Tellez-Iñón1, Mariana Potenza3.   

Abstract

Trypanosomatids are unicellular organisms that colonize a wide diversity of environments and hosts. For instance, Trypanosoma cruzi is a human pathogen responsible for Chagas diseases, while Leishmania tarentolae infects amphibians and became a biotechnological tool suitable for recombinant protein expression. T. cruzi antigens are needed for the development of improved epitope-based methods for diagnosis and treatment of Chagas disease. Molecular cloning for the production of recombinant proteins offers the possibility to obtain T. cruzi antigens at high yield and purity. L. tarentolae appears as the ideal expression host to obtain recombinant T. cruzi antigens with a structure and posttranslational modifications typical of trypanosomatids. In this chapter, we present a protocol for the analytical to mid-scale production of recombinant T. cruzi antigens, using L. tarentolae as expression host (LEXSY® inducible system).

Entities:  

Keywords:  Eukaryotic expression system; Leishmania tarentolae; Recombinant antigen; Trypanosoma cruzi

Mesh:

Substances:

Year:  2019        PMID: 30868522     DOI: 10.1007/978-1-4939-9148-8_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Authors:  Leticia L Niborski; Mariana Potenza; Renato G S Chirivi; Leandro Simonetti; Micaela S Ossowski; Vanina Grippo; Maria May; Daniela I Staquicini; Adriana Parodi-Talice; Carlos Robello; Marcelo A Comini; Guillermo D Alonso; Jos M H Raats; Karina A Gómez
Journal:  EBioMedicine       Date:  2021-01-08       Impact factor: 8.143

2.  Development of a microsphere-based immunoassay for the serological diagnosis of equine trypanosomosis.

Authors:  Mylène Verney; Morgane Gautron; Charlène Lemans; Alain Rincé; Aymeric Hans; Laurent Hébert
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.